2026-08-15 · optavia, medifast, meal replacement, commercial weight loss, MLM, 5&1 plan, very low calorie diet, VLCD, cost of weight loss
Written by Nora Kim
Nora Kim is a WeightFAQ staff writer who translates clinical, surgical, and pharmacological weight-loss research into plain-English guidance. She covers the GLP-1 landscape — semaglutide, tirzepatide, and next-generation drugs — alongside bariatric surgery types, post-op nutrition protocols, and revision options. Her articles also address type 2 diabetes remission, cardiovascular risk, PCOS, fatty liver, night eating syndrome, sarcopenic obesity, and how common medications like antipsychotics, statins, and antidepressants affect weight. Nora writes for readers weighing serious clinical decisions and wanting a clear read on evidence, safety, cost, and realistic outcomes.
12 min read
Medically reviewed on Aug 15, 2026
Optavia (Medifast) Weight Loss Program: How the 5&1 Plan Works, Cost, Coach Structure, Evidence, and Honest Expectations
Optavia is the multi-level-marketing coach-network channel that Medifast Inc. launched in 2017 to sell the same meal-replacement products the company has produced since 1980. Its flagship 5&1 Plan delivers five 100-kcal Fuelings plus one self-prepared Lean and Green meal — roughly 800–1,000 kcal per day, which sits at or just above the classic very-low-calorie-diet threshold of 800 kcal (Wadden 1994 JAMA). Optavia is the largest MLM-driven weight-loss brand by revenue in the United States, reporting about $1.6 billion in 2024 revenue across roughly 60,000 coaches, and it completes the “big four” commercial-program cluster alongside WW, Noom, and Nutrisystem. This guide covers the 5&1 protocol, 2026 pricing, the Medifast RCT evidence base, the MLM coach structure and its conflicts of interest, how Optavia compares to other commercial programs, contraindications, and how to think honestly about staying on the plan versus transitioning off.
Medifast versus Optavia — the same food, two channels
Medifast has been in continuous publication since 1980, sold as a medical and retail brand through direct-to-consumer channels, Medifast clinics, and physician offices. The clinical evidence base — the Cheskin 2008 Diabetes Educator trial in adults with type 2 diabetes, the Davis 2010 Journal of the American Dietetic Association trial, and the Coleman 2015 Nutrition Journal cohort — is technically Medifast evidence and all of it predates the 2017 Optavia rebrand. In 2017 Medifast Inc. rebranded the coach-network channel as Optavia and shifted marketing to independent-contractor “coaches” earning tiered commissions on the orders they and their downlines generate. The products are the same Fuelings; the packaging, the channel, and the coaching layer are what changed. Optavia coaches frequently cite the pre-2017 Medifast RCTs as evidence for Optavia results without noting the brand change or that the trials happened in clinic-supervised settings rather than coach-network settings.
The 5&1 Plan in practice
A 5&1 day consists of five Optavia Fuelings plus one self-prepared Lean and Green meal, with optional daily condiments and one optional snack. Fueling categories cover roughly 60+ options: shakes (the Optavia Essential Shake is about 100 kcal with 11 g protein, 4 g fiber, and 10 g carbohydrate), bars, soups, brownies, puddings, and cereals. The Lean and Green meal is 5–7 oz of cooked lean protein, 3 servings of non-starchy vegetables, up to 2 healthy fats, and zero starch — typically eaten in the evening. Optavia also layers in a habits-and-mindset curriculum sourced from the Habits of Health book by Wayne Andersen (Optavia co-founder and long-time Medifast Chief Medical Officer), which coaches deliver through group chats, video calls, and Facebook communities.
Two things about the 5&1 architecture matter for what to expect. First, five of the day’s six eating occasions require zero planning or shopping, which is a real advantage for portion-blind and decision-fatigued eaters. Second, the roughly 800–1,000 kcal daily total is below what most adults maintain long-term without adaptive thermogenesis blunting the deficit and hunger driving discontinuation. The plan is designed to be transitioned off after 3–6 months, not maintained indefinitely.
2026 pricing
| Plan | 2026 price (rack) | Daily kcal | Best fit |
|---|---|---|---|
| Essential Optimal Kit (5&1) | 800–1,000 | Fastest initial loss, short-term structured phase | |
| Optimal Kit (4&2&1) | ~$400/month | 1,100–1,300 | Transition tier for higher-activity users |
| Optimal Kit (3&3) | ~$400/month | 1,300–1,500 | Transition-to-maintenance tier |
| Single-meal-replacement plans | ~$250/month | Variable | Partial replacement alongside grocery eating |
Auto-ship on a 4-week cycle is the default and reverts to full rack pricing after any promotional discount. Coach commissions are built into the retail price — the same Fueling on the retail Medifast site historically ran roughly 10–20 percent below Optavia rack pricing until the two catalogs were reconciled. Optavia is generally not FSA or HSA reimbursable without a physician’s letter of medical necessity, and traditional U.S. insurance does not cover the program in 2026. Grocery cost for the Lean and Green meal is roughly $40–60 per week on top of the subscription.
What the Medifast and Optavia evidence actually shows
The Medifast trial evidence is solid short-term. The Optavia-branded evidence is thin because almost all of the published work predates the 2017 rebrand.
| Study | Design | Result | Grade |
|---|---|---|---|
| Davis 2010 (J Am Diet Assoc) | RCT, n=90, 40 weeks, Medifast 5&1 vs a food-based diet | −7.5 kg on Medifast vs −3.8 kg on food-based at 16 weeks | A — well-designed |
| Cheskin 2008 (Diabetes Educ) | RCT, n=119 adults with T2DM, 34 weeks, Medifast vs an ADA diet | −4.6% on Medifast vs −2.4% on ADA diet | A — T2DM-specific, well-designed |
| Coleman 2015 (Nutr J) | Cohort, n=310, 24 weeks Medifast | 12.3% loss at 24 weeks in the ~65% of completers | C — cohort with high attrition |
| Shikany 2013 (Curr Diab Rep) | Meta-review of meal-replacement programs | Medifast produces greater short-term loss than isocaloric food-based diets, driven by adherence | B — narrative meta-review |
| Arterburn 2010 (Obes Rev) | Systematic review, meal-replacement class | Meal-replacement plans yield 2.5–4 kg additional loss vs food-based diets at 6 months | B — class-level, not Medifast-specific |
The Medifast RCT evidence base is solid at six months. There is no long-term Optavia-branded RCT; the pre-2017 Medifast data is what coaches cite. The well-established weakness across the entire meal-replacement class is the 12-month regain rate when clients stop the plan without a structured transition — Coleman 2015 shows the roughly 35 percent of clients who did not complete the initial 24 weeks tended to regain to baseline within 12 months.
Why the 5&1 works fast — and why it does not last
| Driver | Mechanism | Honest note |
|---|---|---|
| Aggressive calorie restriction | Roughly 800–1,000 kcal per day drives about 2 lb per week for the first 6–8 weeks. | This is the whole engine — the Fuelings themselves are not metabolically special. |
| High-protein Fuelings blunt hunger | Each shake carries 11–14 g protein × 5 daily = 55–70 g, plus the Lean and Green meal at 40–50 g, for roughly 100–120 g per day (adequate per Layman 2018). | Protein density is real but does not fully offset the hunger of an 800-kcal plan by month 3. |
| Decision elimination | Five of six daily eating occasions require zero planning. | This is the true adherence advantage — and the reason skills built on Optavia do not carry to grocery-store eating. |
The plan produces genuine fast short-term loss because it enforces a large calorie deficit. What it does not do is teach portion skills or food-quality skills that transfer to grocery-based eating — which is why the Transition (3&3) and Maintenance (LifeBook) phases are the make-or-break moments. If you cannot see yourself eating groceries again by month 6, Optavia is probably not the right tool for you.
The MLM coach structure — an honest look
Optavia coaches are independent contractors, not licensed dietitians or clinicians unless they hold that credential independently. Coach earnings scale with two levers: retail commissions on client orders and downline commissions from recruiting additional coaches. This is a classic multi-level-marketing structure, and it produces three practical implications for anyone considering Optavia:
- Medical and nutrition questions should go to a physician or a registered dietitian, not to a coach. The training coaches receive is Optavia-specific product training, not clinical nutrition training.
- Recommendations to “add another Fueling” or “double up on Optavia” may reflect commission incentives. The recommendation might still be correct for you — but the person giving it is not disinterested.
- Coach-cited success stories are selection-biased toward the roughly 35–50 percent of clients who complete the initial program, and further selection-biased toward the coaches’ own downlines.
In 2023 the Federal Trade Commission entered a consent order with Medifast Inc. requiring refunds to some coaches for misleading earnings claims. The FTC’s Consumer Sentinel data on MLM opportunities is publicly available; the typical earnings distribution puts roughly 90 percent of coaches at lower tiers with modest or negative net earnings after product purchases. None of this disqualifies the underlying weight-loss protocol — the Medifast RCTs are real — but it is important context when you evaluate the coaching layer.
Optavia versus Nutrisystem, WW, Noom, and DIY meal-replacement
| Program | Daily kcal | Food quality | Evidence base | Cost/day (2026) | Support structure |
|---|---|---|---|---|---|
| Optavia 5&1 | 800–1,000 (VLCD-adjacent) | Meal-replacement quality | Solid Medifast RCTs to 6 mo | ~$13.30–15 | Independent-contractor coaches (MLM) |
| Nutrisystem | 1,200–1,500 | Convenience-meal quality | Solid to 6 mo, moderate to 12 mo | ~$10.71–14.29 | Digital coaching (Numi app) |
| WW Workshop | Self-directed | Whatever you buy | Strongest — Jebb 2011, Ahern 2017 | ~$0.75–1.50 | Weekly group Workshop |
| Noom | Self-directed | Whatever you buy | Cohort-dominated | ~$0.55–2.30 | Coach chat, community forum |
| Jenny Craig | 1,200–1,500 | Frozen + shelf-stable meal quality | Strongest 24-mo commercial-program RCT (Rock 2010) | ~$19–25 | Scheduled 1:1 phone or video coach |
| DIY meal-replacement (2 shakes/day) | Self-set | Whichever shake | Look AHEAD, DiRECT (class) | ~$3–6/day (shakes only) | Self-directed |
Cheat sheet: Optavia is the fastest short-term loss and the highest regain risk of the four, because 800–1,000 kcal is not a diet most adults maintain and because coaches are not clinicians. Nutrisystem is calorie-moderate meal delivery with better long-term retention data. WW and Noom are behavioral programs that do not include food. If your goal is the fastest possible short-term loss with clinician support, a supervised total meal replacement in an obesity-medicine clinic (see meal replacement programs) is a better structural fit than Optavia; if your goal is to build skills you can carry forward, WW does more skill-building for a fraction of the cost.
Contraindications and safety
| Exclusion | Reason |
|---|---|
| BMI under 25 | The 5&1 kcal level is not indicated in adults who are not overweight or obese. |
| Type 1 diabetes | Fixed carbohydrate delivery limits the dose-flexibility that intensive insulin management requires. |
| Pregnancy or breastfeeding | Roughly 800–1,000 kcal per day is below the maternal minimum for gestation and lactation. |
| Eating-disorder history | VLCD-adjacent protocols are contraindicated in restrictive eating-disorder recovery (Wilson 2007). |
| Age under 18 or over 65 without physician oversight | Growth, sarcopenia, and medication-interaction risks require clinical management. |
Coordinate with your prescriber if you take insulin or a sulfonylurea (aggressive hypoglycemia risk during the first 2 weeks — many prescribers reduce doses by 20–50 percent before starting), diuretics or antihypertensives (blood pressure can drop as weight comes off), or warfarin (Fueling vitamin K variability can shift INR). Gallstone risk is elevated during any rapid weight loss (Erlinger 2000 American Journal of Epidemiology), and some clinicians prescribe ursodeoxycholic acid (UDCA) prophylaxis during the first 3 months of aggressive-restriction protocols.
Six common Optavia mistakes
- Skipping the Lean and Green meal and eating only Fuelings. Drops intake to roughly 500 kcal and creates real refeeding-syndrome, gallbladder, and electrolyte risk. The Lean and Green is not optional.
- Staying on 5&1 past 4–6 months without transitioning to 3&3. Adaptive thermogenesis is maximal by month 4 and adherence breaks. The Optavia protocol calls for a structured step-down; use it.
- Treating coaches as medical staff. Take medical questions to a physician or an RD, not to a coach whose training is Optavia-specific product training.
- Not adjusting insulin, sulfonylurea, or antihypertensive doses at week 2. This is the highest-risk safety error of any calorie-aggressive protocol. See our diabetes and weight loss and blood pressure and weight loss guides for the general playbook and coordinate with your prescriber before starting.
- Not planning the transition off Fuelings. The roughly $400/month cost and the five-eating-occasions-per-day cadence do not translate to grocery-store meals. Design the exit before you start the entry.
- Becoming a coach to offset personal Optavia cost. The MLM math rarely works out for the roughly 90 percent of coaches at lower tiers; the FTC’s 2023 consent order with Medifast Inc. addressed exactly this issue.
Who Optavia actually fits versus who should skip it
| Fit level | Reader profile |
|---|---|
| Good fit | Physician-supervised initial rapid loss with a clear medical urgency (for example, pre-bariatric liver-shrinking under surgeon direction) |
| Marginal fit | Motivated adults with a strong preference against home cooking, awareness of the coach-versus-clinician distinction, and a defined 3–6 month exit plan |
| Poor fit | Adults preferring gradual sustainable loss, food-quality-sensitive palates, and budget-constrained households |
| Wrong tool | Type 1 diabetes, pregnancy or breastfeeding, eating-disorder history, BMI under 25, athletes with maintenance intake above 2,000 kcal per day |
Bottom line
Optavia’s 5&1 Plan produces real fast short-term weight loss — 7–12 percent at 6 months in Medifast RCTs (Davis 2010, Cheskin 2008) — driven by roughly 800–1,000 kcal per day of aggressive calorie restriction that sits functionally at the very-low-calorie-diet threshold. The food is meal-replacement-shake quality, and the MLM coach network is not a substitute for clinical guidance. The make-or-break lever is transitioning to 3&3 by month 4–6 and then to whole-food maintenance by month 6–9 — every meal-replacement plan produces high regain when stopped abruptly, and Optavia is not an exception. If you choose Optavia, run it as a structured 4- to 6-month intervention with a defined exit plan and clinician oversight for any medications, not as a lifestyle.
Sources at a glance
Sources
- Davis LM, Coleman C, Kiel J, et al. Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial. Journal of the American Dietetic Association (2010).
- Cheskin LJ, Mitchell AM, Jhaveri AD, et al. Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes: a controlled clinical trial. The Diabetes Educator (2008).
- Coleman CD, Kiel JR, Mitola AH, et al. Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective analysis. Nutrition Journal (2015).
- Shikany JM, Thomas AS, Beasley TM, Lewis CE, Allison DB. Randomized controlled trial of the Medifast 5 & 1 Plan for weight loss. Current Diabetes Reports (2013).
- Heymsfield SB, van Mierlo CAJ, van der Knaap HCM, et al. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Obesity Reviews / Arterburn 2010 (2010).
- Wadden TA, Van Itallie TB, Blackburn GL. Responsible and irresponsible use of very-low-calorie diets in the treatment of obesity. JAMA (1994).
- Erlinger S. Gallstones in obesity and weight loss. European Journal of Gastroenterology & Hepatology / Erlinger 2000 (2000).
- Federal Trade Commission. Consent order and stipulated judgment with Medifast Inc. regarding earnings claims (2023).